HAVANA, Cuba, Aug 4 (ACN) Cuba's Center for Genetic Engineering and Biotechnology (CIGB) highlighted today the use of national anti-COVID-19 vaccines to combat variants of SARS-CoV-2, the virus that causes the disease.
According to the scientific center's post on X, to strengthen defenses against COVID-19, the Cuban health system is promoting booster vaccinations with Soberana, an immunogen developed by the Finlay Vaccine Institute (IFV).
In addition, the message indicates, for people with specific allergies, doses of the Abdala vaccine (designed and produced by the CIGB) without thiomersal are offered.
Recently, health authorities warned about the possible entry into the country of the XFG subvariant of the omicron strain of SARS-CoV-2.
Francisco Duran, national director of Epidemiology at the Ministry of Public Health, explained that symptoms include hoarseness, sore throat, and mild fever, and can occur in populations with low immunity.
He specified that the currently approved COVID-19 vaccines continue showing efficacy against XFG.
Consequently, the specialist mentioned measures to protect health, including vaccination of vulnerable groups, as well as use of face masks, handwashing, and social distancing for respiratory conditions.
Cuban scientific center highlights use of domestic vaccines against SARS-CoV-2 variants
Nos reservamos el derecho de no publicar los comentario que incumplan con las normas de este sitio